California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

The Food and Drug Administration announced Wednesday that it would ease regulatory roadblocks for low-cost copycat versions ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded ...

MONDAY, Oct. 20, 2025 (HealthDay News) — California will start selling low-cost insulin Jan. 1, nearly three years after Gov.

However Trump continues to battle bruising on his hands and swollen ankles. The White House revealed in July the president ...

Ingestible electronics. Microneedle patches. A capsule that could replace insulin shots. In Giovanni Traverso’s lab, the ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

Authorities have filed 73 charges, including 50 felonies, against Crystal Scott, who is accused of posing as a nurse and administering insulin to children as young as five. The Las Vegas Metropolitan ...

First there were Victoza and Saxenda, then Ozempic seized the spotlight - followed by Wegovy and Mounjaro. And ever-better products have been promised soon.